Ferring sales and marketing update

Ferring's Ferring Pharmaceuticals Inc. subsidiary launched its Lysteda tranexamic acid tablets in the U.S. to treat menorrhagia. The wholesale acquisition cost (WAC) for 650 mg tablets is $145 for 30...